Insider Buying: Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Acquires $20,998.57 in Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon acquired 14,093 shares of the stock in a transaction dated Tuesday, October 13th. The stock was bought at an average price of $1.49 per share, for a total transaction of $20,998.57. Following the purchase, the chief executive officer owned 14,093 shares of the company’s stock, valued at $20,998.57. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Friday, October 9th, Dagi Ben-Noon bought 18,181 shares of Inspira Technologies OXY B.H.N. stock. The shares were bought at an average cost of $1.67 per share, for a total transaction of $30,362.27.
• On Monday, September 28th, Dagi Ben-Noon bought 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were bought at an average price of $0.71 per share, with a total value of $119,914.74.

Inspira Technologies OXY B.H.N. Price Performance

Shares of Inspira Technologies OXY B.H.N. stock opened at $1.58 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.00 and a debt-to-equity ratio of 0.12. Inspira Technologies OXY B.H.N. Ltd has a fifty-two week low of $0.28 and a fifty-two week high of $3.85. The firm has a fifty day moving average of $1.00.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last posted its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has approved a share buyback plan on Monday, June 22nd that authorizes the company to repurchase 2,000,000,000,000 outstanding shares. This buyback authorization authorizes the company to repurchase up to 5.6% of its shares through open market purchases. Share buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Weiss Ratings downgraded Inspira Technologies OXY B.H.N. from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, October 9th. Wall Street Zen cut Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a report on Saturday, August 8th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.